Updates

January 4, 2021January 4, 2021
Health, Financial Impact of Acute Kidney Injury Similar With or Without Sjögren’s

In-hospital mortality, the length of a hospital stay, and hospitalization charges for people with acute kidney injury and Sjögren’s syndrome are no different from ... Read more
December 22, 2020January 11, 2021
Electrical Brain Stimulation Found to Safely Reduce Sjogren’s Fatigue

A technique that delivers low electric currents to stimulate specific parts of the brain can safely reduce fatigue in people with primary Sjogren’s syndrome ... Read more
December 21, 2020December 21, 2020
Higher Risk of Blood Clots With COVID-19 Infection Seen in Study

People with Sjögren’s syndrome and other systemic autoimmune rheumatic diseases (SARDs) may be at a greater risk of severe complications from COVID-19 than people ... Read more
December 14, 2020December 14, 2020
RSLV-132 Lowers Fatigue in Primary Sjögren’s Patients in Phase 2 Trial

RSLV-132, an investigational treatment for autoimmune conditions, led to significant and clinically meaningful reductions in patient-reported fatigue in people with primary Sjögren’s syndrome, results from ... Read more
December 7, 2020December 7, 2020
Study Links Altered Gut Microbiome in Sjogren’s to Systemic Inflammation

Primary Sjogren’s syndrome (pSS) patients have less diversity in their gut microbiome — with less abundant beneficial bacteria but more abundant opportunistic bacteria with ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

May 22, 2018

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome

News

Researchers recently identified an autoantibody — an antibody produced against a person’s own tissue or molecule — significantly associated with the peripheral nerve damage common in Sjögren’s syndrome patients. This finding may help scientists understand the cause and development of ... Read more

Updates

Health, Financial Impact of Acute Kidney Injury Similar With or Without Sjögren’s

Electrical Brain Stimulation Found to Safely Reduce Sjogren’s Fatigue

Higher Risk of Blood Clots With COVID-19 Infection Seen in Study

RSLV-132 Lowers Fatigue in Primary Sjögren’s Patients in Phase 2 Trial

Study Links Altered Gut Microbiome in Sjogren’s to Systemic Inflammation

Sjogren’s Foundation Welcomes Applications for 2021 Research Grants

New $100M Program Aims to Improve Diversity in Clinical Trials

Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests

LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures

Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests

Study Links Immune Regulatory Molecule NEAT1 to Primary Sjogren’s

Subscribe to our mailing list

Seletalisib Shows Trend Toward Easing Primary Sjögren’s in Phase 2 Trial

$3.7M NIH Grant Will Support Research to Pinpoint Genes Associated With Sjögren’s

Endoscopic Irrigation Brings Long-term Oral Relief to Sjögren’s Patients in Trial

Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds

Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests

Attention Deficits May Underlie Cognitive Impairment in Neuro‐Sjögren’s, Study Finds

Tumor Markers in Blood May Help Diagnose Lung Disease in Sjögren’s Patients, Study Finds

Increased Gene Activity Linked to Immune Cell Malfunction, Study Reveals

Unexplained Kidney, Neurological Problems, Fever Could Be Sjögren’s, Case Study Suggests

Saliva Levels of IL-6 Protein May Help in Diagnosing Primary Sjögren’s

Severe Dryness Symptoms Increase Risk of Cavities, Oral Candida, Study Finds

Australian Partnership to Advance Technology to Treat Sjogren’s

Luminary Therapeutics, Case Western Team Up to Develop New CAR T-Cell Therapy

Researchers Discover Two Potential Biomarkers for Primary Sjögren’s Syndrome

Bcl-6 ‘Master Regulator’ Discovery Sheds Light on Autoimmune Diseases Such as Sjogren’s

B-cell Protein May Contribute to Development of Primary Sjogren’s Syndrome, Study Suggests

Wize Completes Phase 4 Study of LO2A Eye Drops for Sjögren’s; Results Expected Later This Year

Researchers Shed Light on Genetics Behind Sex-based Vulnerability to Sjögren’s, Other Diseases

Research Implicates MicroRNA in Primary Sjögren’s Syndrome Eye Inflammation

Damage to Eye Surface Evident in Sjögren Patients, Study Reports

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome